Processing of voided urine for prostate cancer RNA biomarker analysis (Q40308110)

19 September 2017

title

Processing of voided urine for prostate cancer RNA biomarker analysis (English)

1 reference

Ricardo Zorzetto Nicoliello Vêncio

19 September 2017

0 references

1 reference

object named as

Ricardo Z N Vêncio

1 reference

19 September 2017

Sue-Ing Quek

1 reference

19 September 2017

Olivia M Wong

1 reference

19 September 2017

Adeline Chen

1 reference

19 September 2017

Gisely T Borges

1 reference

19 September 2017

William J Ellis

1 reference

19 September 2017

Diego M Salvanha

1 reference

19 September 2017

Brandi Weaver

1 reference

19 September 2017

Yasmin M Ench

1 reference

19 September 2017

Robin J Leach

1 reference

19 September 2017

Ian M Thompson

1 reference

19 September 2017

Alvin Y Liu

1 reference

19 September 2017

publication date

26 August 2015

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

1 reference

19 September 2017

page(s)

1886-1895

1 reference

From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Development of an ELISA to detect the secreted prostate cancer biomarker AGR2 in voided urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

A multiplex assay to measure RNA transcripts of prostate cancer in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Prostate cancer biomarker profiles in urinary sediments and exosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Application of Affymetrix array and Massively Parallel Signature Sequencing for identification of genes involved in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Temporal expression profiling of the effects of secreted factors from prostate stromal cells on embryonal carcinoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Transcriptomes of human prostate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Bladder expression of CD cell surface antigens and cell-type-specific transcriptomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Lineage relationship of prostate cancer cell types based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Cell–cell interaction in prostate gene regulation and cytodifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Differential expression of CD10 in prostate cancer and its clinical implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Periostin is up-regulated in high grade and high stage prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Analysis of prostate cancer by proteomics using tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Concordance between transrectal ultrasound guided biopsy results and radical prostatectomy final pathology: Are we getting better at predicting final pathology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Exosomes as Biomarker Treasure Chests for Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Expressed prostatic secretion biomarkers improve stratification of NCCN active surveillance candidates: performance of secretion capacity and TMPRSS2:ERG models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

Prostasomes: extracellular vesicles from the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.23066

21 January 2018

Identifiers

DOI

10.1002/PROS.23066

1 reference

19 September 2017

1 reference